Blog

Sankalp Arora Presents FLT3-TKD AML Data at HOP Meeting in Austin

Sankalp Arora/X

May 6, 2025, 08:41

Sankalp Arora Presents FLT3-TKD AML Data at HOP Meeting in Austin

Sankalp Arora, Hematology/Medical Oncology Fellow at MD Anderson Cancer Center, shared in a post on X.

“An end to an amazing HOP live meeting at aust in texas. Incredible opportunity to learn from and network with experts in all facets of hematologic malignancies! Also honored to present our FLT3-TKD AML data at the ‘Emerging Experts’ Fellows session!”

Sankalp Arora highlighted his participation in the Hematologic Oncology Progress (HOP) live meeting held in Austin, Texas, where he had the honor of presenting new data on FLT3-TKD mutations in acute myeloid leukemia (AML). His presentation was featured in the “Emerging Experts” Fellows session, recognizing early-career researchers making an impact in hematologic oncology. Arora also emphasized the value of networking and learning from leading experts across various specialties within hematologic malignancies.

More posts featuring Sankalp Arora on OncoDaily.

academic presentations AML research cancer cancer conferences emerging experts FLT3-TKD hematologic malignancies HOP 2025 MD Anderson Cancer Center OncoDaily Oncology oncology fellows Sankalp Arora

USA vs Europe: Who Does Cancer Screening Better?

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action